Delivery Order SPE2DB20D9329-SPE2DB25FZK33

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 units of the pharmaceutical product XTANDI 40 MG CAPSULE. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA's Medical Supply Chain division, valued at up to $499,999,999. The IDC runs through December 31, 2025...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 Firm Fixed Price delivery order contract is for the provision of XTANDI 40 MG CAPSULE 120S to support the recurring medical supply needs of military health facilities. This award is under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, with a performance period ending on July 19, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program,...
This federal contract award was granted by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,245.40 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
The U.S. government awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,695.90 contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division, is for the delivery of the medication XTANDI 40 MG TABLET 120S. This contract award is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,111.35 firm fixed-price delivery order is for the supply of 120 capsules of the prescription drug XTANDI 40 MG. The contract has an ultimate completion date of May 29, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $12,934.05, for the provision of XTANDI 40 MG CAPSULE 120S. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order valued at $8,622.72, is for the supply of XTANDI 40 MG CAPSULE 120S to support the recurring medical needs of military healthcare facilities worldwide. The contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that...
  • SPE2DB20D9329
    Indefinite Delivery Contract
  • SPE2DB20D9329-SPE2DB25FZK33
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of 120 capsules of the prescription drug XTANDI 40 MG. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, and DMS Pharmaceutical Group has consistently secured federal pharmaceutical contracts by leveraging its status as a woman-owned small business.

Generated 9/4/25, 9:55 AM